News - Page 32 - Psychedelic Alpha

Read more about the article COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights

COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights

Post published:August 3, 2023
Post category:Press Release

Read more about the article Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement

Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement

Post published:August 2, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement

Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement

Post published:August 1, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Post published:August 1, 2023
Post category:Press Release

Read more about the article Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

Post published:August 1, 2023
Post category:Press Release

Read more about the article Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics; Couple Receives First Psilocybin Services in Oregon; Mass. Ballot Measure Ramps Up; NIDA and NIMH Directors Opine

Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics; Couple Receives First Psilocybin Services in Oregon; Mass. Ballot Measure Ramps Up; NIDA and NIMH Directors Opine

Post published:July 31, 2023
Post category:Psychedelic Bulletin

Read more about the article COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

Post published:July 31, 2023
Post category:Press Release

Read more about the article Analysis: Patent Applications Provide Hints at Terran Biosciences’ Strategy

Analysis: Patent Applications Provide Hints at Terran Biosciences’ Strategy

Post published:July 28, 2023
Post category:Analysis

Read more about the article Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents

Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents

Post published:July 28, 2023
Post category:Press Release

Read more about the article MIND CURE ANNOUNCES LNG ENERGY GROUP CREDIT AGREEMENT IN THE AMOUNT OF U.S. $70 MILLION TO ACQUIRE LEWIS ENERGY COLOMBIA, INC.

MIND CURE ANNOUNCES LNG ENERGY GROUP CREDIT AGREEMENT IN THE AMOUNT OF U.S. $70 MILLION TO ACQUIRE LEWIS ENERGY COLOMBIA, INC.

Post published:July 28, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.